Unlock instant, AI-driven research and patent intelligence for your innovation.

Metastatic breast cancer markers and applications in diagnosis and treatment

A technology for metastatic breast cancer and breast cancer, applied in the field of oncology and diagnosis, can solve the problems of dependence, patient harm, and failure to meet the clinical needs of patients with multi-target organ metastasis risk

Inactive Publication Date: 2018-11-13
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Past studies identified several associated genes specific to bone or lung metastases 1-3 , but the specific associated genes targeting only a single target organ still cannot meet the clinical needs of simultaneously predicting the risk of metastasis in patients with multiple target organs
Moreover, even if these genes are used as biological markers, they mostly rely on invasive detection methods such as puncture, which are likely to cause additional harm to patients
[0003] In addition, although there were some drug regimens for the treatment of organ-specific metastases in the past, they only targeted a single target organ.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Metastatic breast cancer markers and applications in diagnosis and treatment
  • Metastatic breast cancer markers and applications in diagnosis and treatment
  • Metastatic breast cancer markers and applications in diagnosis and treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0165] Expression patterns of DKK1 in breast cancer samples

[0166] Through the enzyme-linked immunosorbent assay (ELISA) of the patient's serum, it was found that the serum DKK1 protein level of breast cancer patients in the bone metastasis group was significantly higher than that of the control group without metastasis, while the DKK1 protein level of patients in the lung metastasis group was significantly lower than that of the control group ( figure 1 a). Moreover, the lung metastasis-free survival rate of patients in the high serum DKK1 group was significantly higher than that in the low DKK1 group, and the opposite was true in the bone metastasis-free survival rate ( figure 1b). Previous studies have almost never reported biomarkers similar to DKK1 with opposite expression patterns in different tissue-specific metastases, indicating that DKK1 has the potential to become a new class of biomarkers that simultaneously predict bone and lung metastases in breast cancer. Po...

Embodiment 2

[0170] Functional study of DKK1 in group-specific metastasis of breast cancer

[0171] To test whether DKK1 is functional in breast cancer tissue-specific metastasis, DKK1 was overexpressed in the luciferase-labeled MDA-MB-231 breast cancer cell line (obtained from Joan Massague's lab), and the cells were passed through tail Intravenous and left atrium injection into immunodeficient mice (purchased from Shanghai Slack Experimental Animal Co., Ltd.), through the injection of luciferase substrate, the light signal corresponding to the transfer load can be observed. Consistent with clinical relevance, light signaling from tumor cells revealed that overexpressed DKK1 significantly suppressed breast cancer lung metastasis and significantly enhanced bone metastasis ( figure 1 c, d, e).

Embodiment 3

[0173] Mechanism of action of DKK1

[0174] DKK1 is an inhibitory protein of the canonical WNT signaling pathway. The study of the present invention found that DKK1 regulates the recruitment and important cytokines of microenvironmental cells (macrophages and myeloid-derived immunosuppressive cells, MDSC) in lung metastases through non-canonical WNT signaling pathways—JNK and NF-κB pathways. TGFβ secretion affects the growth of lung metastases. DKK1 can inhibit the phosphorylation level of the transcriptional regulator JUN downstream of the JNK pathway, thereby reducing its transcriptional activity, resulting in a decrease in the expression of downstream genes, and inhibiting the ability of tumor cells to produce factors that attract macrophages / MDSCs ( figure 2 a); at the same time, DKK1 can also inhibit the phosphorylation level of RELA, an important transcriptional regulator of the NF-κB pathway, thereby reducing the secretion of downstream TGFβ ( figure 2 b), jointly i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to metastatic breast cancer markers and applications in diagnosis and treatment. Concretely, the invention provides the following applications of a DKK1 gene, mRNA, cDNA or protein or detection reagents thereof: (i) being used for the markers detecting metastatic breast cancer; and / or (ii) being used for preparing diagnostic reagents or reagent kits detecting the metastaticbreast cancer. The experiment results show that the DKK1 can be used as a biological marker for predicting bone and lung metastasis of breast cancer and has great application prospects in comprehensively assessing the risk of metastasis of multiple target organs and guiding the treatment.

Description

technical field [0001] The present invention relates to the fields of oncology and diagnostics. More specifically, the present invention relates to a metastatic breast cancer marker and its application in diagnosis and treatment. Background technique [0002] Distant metastasis of breast cancer is the main cause of breast cancer treatment failure and patient death. The main distant metastatic target organs of breast cancer are bone and lung. An important clinical phenomenon is that the metastasis of breast cancer is organ-specific, that is, tumor cells that invade and migrate from tumor in situ in some patients are prone to bone metastasis, while other patients are prone to lung metastasis. Therefore, the development of biomarkers specific to metastatic organs plays an important role in predicting patients' risk of metastasis and determining treatment options. Past studies identified several associated genes specific to bone or lung metastases 1-3 , but the specific asso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886G01N33/574
CPCC12Q1/6886C12Q2600/118C12Q2600/158G01N33/57415G01N33/57484G01N2800/50G01N2800/52
Inventor 胡国宏壮雪倩
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI